Skip to main content
. 2020 Dec 4;11:595254. doi: 10.3389/fphar.2020.595254

TABLE 5.

The detailed information of compounds from Xiao-Xu-Ming Decoction.

Compound Targets Inhibition (%) against AChE CDOCKER interaction energy of compounds interacting with AChE
Baicalein ALOX12, ACAT1, APP, BACE1, CDK5, PTGS2, ESR1, GABRG1, GSK3B, MAOB, TNF 3.35 41.0117
Chrysin ALOX12, APP, BACE1, CDK5, PTGS2, ESR1, GABRG1, GSK3B, MAPK10, MAOB, TNF −1.31 40.5337
Dauricine ALOX12, HTR1A, HTR3A, HTR6, ACHE, APP, BCHE, PTGS2, GABRG1, PDE4B, SIGMAR1 42.06 84.4849
Fangchinoline HTR1A, HTR3A, HTR6, ACHE, CHRNA7, APP, BCHE, PTGS2, GABRG1, PDE4B, SIGMAR1 72.13 55.9794
Oroxylin A ALOX12, ACHE, APP, BACE1, CDK5, PTGS2, ESR1, GABRG1, GSK3B, MAOB, MAPT, TNF −2.99 46.1022
Quercetin ALOX12, ACHE, APP, CDK5, PTGS2, ESR1, GABRG1, GSK3B, MAPK10, MAOB, MAPT, TNF −4.96 43.9071
Wogonin ALOX12, ACHE, APP, BACE1, CDK5, PTGS2, ESR1, GABRG, GSK3B, MAOB, MAPT, TNF 7.98 41.485